Octagon Capital Advisors LP Terns Pharmaceuticals, Inc. Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
A detailed history of Octagon Capital Advisors LP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 1,364,400 shares of TERN stock, worth $9.47 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
1,364,400
Previous 625,000
118.3%
Holding current value
$9.47 Million
Previous $4.1 Million
126.67%
% of portfolio
2.15%
Previous 0.64%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
136Shares Held
63.6MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$52.9 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$42.9 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$42.3 Million1.36% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.95MShares$34.3 Million3.41% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$28.6 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $261M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...